Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic factors of patients (pts) with salvage-line metastatic colorectal cancer (mCRC).
Authors
Hideaki Bando
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Hideaki Bando , Eiji Oki , Yuriko Takeda , Toshihiro Misumi , Motoko Suzuki , Masashi Wakabayashi , Kentaro Yamazaki , Axel Grothey , Robert J. Mayer , Jin Li , Thierry Andre , Qian Shi , Aimery De Gramont , Takayuki Yoshino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 115)
DOI
10.1200/JCO.2024.42.3_suppl.115
Abstract #
115
Poster Bd #
G19
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Exploratory analysis of the effect of FTD/TPI in patients treated in RECOURSE by prognostic factors.
First Author: Josep Tabernero
Poster
2024 ASCO Gastrointestinal Cancers Symposium
An ARCAD database nomogram for prognostic prediction of treatment refractory metastatic colorectal cancer.
First Author: Eiji Oki
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Updated analysis: Effect of biweekly dosing schedule of trifluridine-tipiracil (TAS-102) on rates of myelosuppression and maintenance of therapeutic efficacy in patients (pts) with previously treated metastatic colorectal cancer (mCRC).
First Author: Christopher G Cann
Poster
2020 Gastrointestinal Cancers Symposium
Exploratory analysis of trifluridine/tipiracil in late-stage metastatic colorectal cancer (mCRC): Prognostic factors.
First Author: Meinolf Karthaus